All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
FDA approves updated Novavax COVID-19 vaccine
Oct 04, 2023
The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Rehabilitation interventions aid post-COVID-19 condition
Sep 20, 2023
A review and meta-analysis show improvements in functional exercise capacity versus standard of care.
Immune response not inferior with coadministration of COVID-19, flu shots
Sep 14, 2023
A similar immune response and no increase in the rate of reactogenicity events was seen with coadministration versus administering the COVID-19 vaccine alone.
Overestimation of oxygen saturation leads to delayed COVID-19 treatment
Aug 31, 2023
Patients with unrecognized need for COVID-19 therapy appear to have higher odds of readmission, regardless of race.
US wastewater tests spot highly mutated variant of COVID-19
Aug 24, 2023
Officials did not specify where the samples were from; most patients infected with new BA.2.86 variant have had mild symptoms.
Incidence of new-onset HTN higher for COVID-19 versus influenza patients
Aug 21, 2023
Hospitalized and nonhospitalized patients with COVID-19 were more likely to develop persistent hypertension than those with influenza.
Biden administration launches office for long COVID research
Aug 01, 2023
The Office of Long COVID Research and Practice will lead the US response to long COVID, which includes trials that already have been launched.